Successful use of methadone in neuropathic pain: A multicenter study by the National Forum of Independent Pain Clinicians

Pain Digest

Volumn 9, Issue 3, 1999, Pages 191-193

  Mironer, Y Eugene ^a   Haasis III, John C ^a   Chapple, Iva T ^b   Somerville, Judson J ^c   Barsanti, John M ^d  

^a Carolinas Center for Advanced Management of Pain   (United States)

^b Carolina Pain Specialists   (United States)

^c Pain Management Clinic of Laredo   (United States)

^d MCV Pain Management Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; FENTANYL; GABAPENTIN; METHADONE; PARACETAMOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NEUROPATHY; ORAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0033047560     PISSN: 09389016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Urban BJ, France RD, Steinberger EK et al: Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 1986;24:191-196
2. Mironer YE, Wade JB, Rafii A et al: A Prospective Study of Low Dose Methadone in Chronic Nonmalignant Pain. Presented at the 15th American Pain Society Annual Scientific Meeting, Washington, DC, 1996
3. Maciewicz R, Bouckoms A, Martin JB: Drug therapy of neuropathic pain. Clin J Pain 1985;1:39-49
4. Niv D, Lang E, Wolman I: Postherpetic neuralgia: What do we know and where are we heading? Pain Digest 1998;8:73-79
5. Magnuson S, Ridgeway B, Wallace M et al: Oral Mexiletine in the Treatment of Neuropathic Pain. Presented at the 16th American Pain Society Annual Scientific Meeting, New Orleans, LA, October 1997
6. Rowbotham MC, Forde G, Twilling L et al: Controlled Trial of Opioids for Neuropathic Pain of CNS and PNS Origin. Presented at the 16th American Pain Society Annual Scientific Meeting, New Orleans, LA, October 1997
7. Loeser JD: Peripheral nerve disorders. In Bonica JJ (ed): The Management of Pain. Philadelphia, Lea & Febiger, 1990, pp 211-219
8. Coyle DE: Efficacy of animal models for neuropathic pain. Pain Digest 1996;6:7-20
9. Dickenson AH: NMDA receptor antagonists as analgesics. In Fields HL (ed): Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle, IASP Press, 1994, pp 173-188
10. Yaksh TL, Malmberg AB: Interaction of spinal modulatory receptor systems. In Fields HL (ed): Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle, IASP Press, 1994, pp 151-171
11. Sang CN, Parada S, Booher S et al: A Double-blinded Randomized Controlled Trial of Dextromethorphan versus Memantine versus Placebo in Patients with Painful Diabetic Neuropathy and Post-herpetic Neuralgia. Presented at the 16th American Pain Society Annual Scientific Meeting, New Orleans, LA, October 1997
12. Foley KM: The "decriminalization" of cancer pain. In Stratton Hill C, Fields WS (eds): Drug Treatment of Cancer Pain in a Drug Oriented Society. New York, Raven Press, 1989, pp 5-18
13. Benedetti C, Butler SH: Systemic analgesics. In Bonica JJ (ed): The Management of Pain. Philadelphia, Lea & Febiger, 1990, pp 1640-1675
14. Jamison RN, Andersen KO, Peeters-Asdourian C et al: Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth 1994;19:225-230
15. Green J, Mickey S, Ansbacher S et al: Methadone use in a small series of selected patients with chronic nonmalignant pain. Pain Digest 1996; 6:3-6
16. Dunbar SA, Katz NP: Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage 1996;11:163-171
17. Kell MJ: Long-term methadone maintenance for intractable, nonmalignant pain: Pain control and plasma opioid levels. AJPM 1994;4:10-16
18. Gorsky BH: A management plan based on experience in a pain clinic. Postgrad Med 1979;66:147-154
19. Fainsinger R, Schoeller T, Bruera E: Methadone in the management of cancer pain: A review. Pain 1993;52:137-147
20. Morley JS, Watt JW, Wells JC et al: Methadone in pain uncontrolled by morphine. Lancet 1993;342:1243
21. Sjorgren P, Jensen N, Jensen TS: Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994;59:313-316
22. Rogers AG: The use of methadone in opioid-tolerant patients. J Pain Symptom Manage 1988;3:45
23. Bruera E, Watanabe S, Fainsinger RL et al: Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 1995;62:141-146
24. Crews JC, Sweeney NJ, Denson DD: Clinical efficacy of methadone in patients refractory to other μ-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer 1993;72:2266-2272
25. Inturrisi CE, Davis AM, Shimoyama N et al: D-methadone has NMDA Receptor Antagonist Activity and Prevents the Development of Tolerance to Morphine. Presented at the 16th American Pain Society Annual Scientific Meeting, New Orleans, LA, October 1997
26. Trujillo KA, Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991;251:85-87
27. Yamamoto T, Yaksh TL: Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 1992;135:67-70
28. Price DD, Mao J, Mayer DJ: Central neural mechanisms of normal and abnormal pain states. In Fields HL (ed): Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle, IASP Press, 1994
29. Chapman V, Dickenson AH: The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 1992;573:321-332